U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496749) titled 'KD Treatment for Super-refractory Status Epilepticus' on Dec. 23, 2024.
Brief Summary: The purpose of the study is to investigate to evaluate the efficacy and safety of ketogenic diet (KD) as an adjunctive therapy in patients with Super Refractory Status Epilepticus (SRSE) in the intensive care unit (ICU).
Study Start Date: Oct. 20, 2025
Study Type: INTERVENTIONAL
Condition:
Super-refractory Status Epilepticus
Intervention:
OTHER: the ketogenic diet
First, ketogenic formulation was initiated continuously via naso-enteric tube at 50% of goal and increase to goal (25-30 kcal/kg/day) within 72h. The KD regimen was continued acc...